Trial Profile
Evaluation of Antiplatelet Therapy in Lower Limb Endovascular Treatment.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 May 2017
Price :
$35
*
At a glance
- Drugs Cilostazol (Primary) ; Aspirin
- Indications Embolism and thrombosis; Peripheral arterial disorders; Restenosis
- Focus Therapeutic Use
- Acronyms STOP-IC
- 19 Jun 2009 New source identified and integrated (University Hospital Medical Information Network - Japan UMIN000002091).
- 16 Jun 2009 New trial record